ALMR
Alamar Biosciences, Inc.
Company overview
- Market capitalization
- $2.26B
- Employees
- 222
- Latest publication
- 2026-09-29
About Alamar Biosciences, Inc.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q1 20252025-03-31 · USD |
|---|---|---|
| Total Revenue | 26,035,000USD | 13,091,000USD |
| Cost Of Revenue | 11,578,000USD | 6,702,000USD |
| Gross Profit | 14,457,000USD | 6,389,000USD |
| Research Development | 13,017,000USD | 8,302,000USD |
| Selling General Administrative | 13,787,000USD | 6,640,000USD |
| Total Operating Expenses | 26,804,000USD | 21,644,000USD |
| Operating Income | -12,347,000USD | -8,553,000USD |
| Interest Income | 539,000USD | 786,000USD |
| Interest Expense | 223,000USD | 46,000USD |
| Net Interest Income | 316,000USD | 740,000USD |
| Income Before Tax | -20,861,000USD | -7,659,000USD |
| Income Tax Expense | 464,000USD | — |
| Tax Provision | 464,000USD | 0USD |
| Net Income | -21,325,000USD | -7,659,000USD |
| Net Income From Continuing Ops | -21,325,000USD | -7,659,000USD |
| Ebit | -12,347,000USD | — |
| Ebitda | -11,180,000USD | — |
| Depreciation And Amortization | 1,167,000USD | — |
| Reconciled Depreciation | 1,167,000USD | 888,000USD |
| Total Other Income Expense Net | -8,514,000USD | 154,000USD |
| Unclassified Operating Expenses | — | 6,702,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Total Revenue | 74,211,000USD | 25,142,000USD |
| Cost Of Revenue | 32,506,000USD | 16,535,000USD |
| Gross Profit | 41,705,000USD | 8,607,000USD |
| Research Development | 37,471,000USD | 39,234,000USD |
| Selling General Administrative | 35,568,000USD | 18,941,000USD |
| Total Operating Expenses | 73,039,000USD | 74,710,000USD |
| Operating Income | -31,334,000USD | -49,568,000USD |
| Interest Income | 2,160,000USD | 4,675,000USD |
| Interest Expense | 401,000USD | 2,078,000USD |
| Net Interest Income | 1,759,000USD | 2,597,000USD |
| Income Before Tax | -29,154,000USD | -47,060,000USD |
| Income Tax Expense | 665,000USD | — |
| Tax Provision | 665,000USD | 13,000USD |
| Net Income | -29,819,000USD | -47,073,000USD |
| Net Income From Continuing Ops | -29,819,000USD | -47,073,000USD |
| Ebit | -31,334,000USD | — |
| Ebitda | -27,470,000USD | — |
| Depreciation And Amortization | 3,864,000USD | — |
| Reconciled Depreciation | 3,864,000USD | 3,194,000USD |
| Total Other Income Expense Net | 2,180,000USD | -89,000USD |
| Unclassified Operating Expenses | — | 16,535,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD |
|---|---|
| Total Assets | 186,451,000USD |
| Intangible Assets | 1,836,000USD |
| Other Current Assets | 12,532,000USD |
| Total Liab | 364,522,000USD |
| Total Stockholder Equity | -178,071,000USD |
| Other Current Liab | 14,704,000USD |
| Common Stock | 1,000USD |
| Capital Stock | 1,000USD |
| Retained Earnings | -190,100,000USD |
| Cash | 64,586,000USD |
| Cash And Short Term Investments | 64,586,000USD |
| Total Current Assets | 136,573,000USD |
| Total Current Liabilities | 24,048,000USD |
| Current Deferred Revenue | 2,110,000USD |
| Net Debt | 275,959,000USD |
| Short Term Debt | 1,599,000USD |
| Short Long Term Debt Total | 340,545,000USD |
| Long Term Debt | 74,971,000USD |
| Net Receivables | 19,524,000USD |
| Inventory | 39,931,000USD |
| Accounts Payable | 5,635,000USD |
| Property Plant Equipment Net | 36,143,000USD |
| Property Plant Equipment Gross | 36,143,000USD |
| Accumulated Other Comprehensive Income | -80,000USD |
| Common Stock Shares Outstanding | 69,311,186shares |
| Non Current Assets Total | 49,877,999USD |
| Non Current Liabilities Total | 340,474,000USD |
| Non Current Liabilities Other | 1,197,000USD |
| Non Currrent Assets Other | 6,991,999USD |
| Net Working Capital | 117,425,000USD |
| Unclassified Non Current Assets | 4,907,000USD |
| Unclassified Non Current Liabilities | 264,306,000USD |
| Unclassified Equity | 12,107,000USD |
| Source | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Total Assets | 139,992,000USD | 149,511,000USD |
| Intangible Assets | 1,988,000USD | 2,044,000USD |
| Other Current Assets | 13,468,000USD | 5,609,000USD |
| Total Liab | 298,946,000USD | 282,922,000USD |
| Total Stockholder Equity | -158,954,000USD | -133,411,000USD |
| Other Current Liab | 15,289,000USD | — |
| Common Stock | 1,000USD | — |
| Capital Stock | 1,000USD | 1,000USD |
| Retained Earnings | -168,775,000USD | -138,956,000USD |
| Cash | 30,002,000USD | 26,770,000USD |
| Cash And Short Term Investments | 30,002,000USD | — |
| Total Current Assets | 94,705,000USD | 106,697,000USD |
| Total Current Liabilities | 23,730,000USD | 16,591,000USD |
| Current Deferred Revenue | 470,000USD | — |
| Net Debt | 11,471,000USD | — |
| Short Term Debt | 2,099,000USD | — |
| Short Long Term Debt Total | 41,473,000USD | — |
| Long Term Debt | 9,810,000USD | — |
| Short Term Investments | 0USD | 52,588,000USD |
| Net Receivables | 12,753,000USD | 6,648,000USD |
| Inventory | 38,482,000USD | 14,408,000USD |
| Accounts Payable | 5,872,000USD | 6,187,000USD |
| Property Plant Equipment Net | 36,628,000USD | 35,097,000USD |
| Property Plant Equipment Gross | 44,965,000USD | 40,654,000USD |
| Accumulated Other Comprehensive Income | -72,000USD | — |
| Common Stock Shares Outstanding | 66,521,424shares | 66,521,425shares |
| Non Current Assets Total | 45,287,000USD | 42,814,000USD |
| Non Current Liabilities Total | 275,216,000USD | 266,331,000USD |
| Non Current Liabilities Other | 599,000USD | — |
| Non Currrent Assets Other | 6,671,000USD | 5,673,000USD |
| Net Working Capital | 70,975,000USD | 90,106,000USD |
| Unclassified Non Current Liabilities | 264,807,000USD | 266,331,000USD |
| Unclassified Equity | 9,891,000USD | 5,544,000USD |
| Unclassified Current Liabilities | — | 10,404,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q1 20252025-03-31 · USD |
|---|---|---|
| Net Income | -21,325,000USD | -7,659,000USD |
| Depreciation | 1,167,000USD | 888,000USD |
| Stock Based Compensation | 1,467,000USD | 619,000USD |
| Other Non Cash Items | 11,199,000USD | 507,000USD |
| Change To Account Receivables | -6,854,000USD | -533,000USD |
| Change To Inventory | -1,265,000USD | -2,357,000USD |
| Change In Working Capital | -11,388,000USD | -7,062,000USD |
| Total Cash From Operating Activities | -20,347,000USD | -13,068,000USD |
| Capital Expenditures | -600,000USD | -982,000USD |
| Free Cash Flow | -20,947,000USD | -14,050,000USD |
| Investments | 0USD | 18,000,000USD |
| Total Cashflows From Investing Activities | -778,000USD | — |
| Net Borrowings | 56,500,000USD | 0USD |
| Total Cash From Financing Activities | 55,761,000USD | 243,000USD |
| Issuance Of Capital Stock | 1,803,000USD | 243,000USD |
| Change In Cash | 64,586,000USD | 4,326,000USD |
| Begin Period Cash Flow | 34,909,000USD | 31,677,000USD |
| End Period Cash Flow | 64,586,000USD | 36,003,000USD |
| Unclassified Operating Cash Flow | -1,467,000USD | — |
| Unclassified Financing Cash Flow | -2,542,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Net Income | -29,819,000USD | -47,073,000USD |
| Depreciation | 3,864,000USD | 3,194,000USD |
| Stock Based Compensation | 2,870,000USD | 873,000USD |
| Other Non Cash Items | 2,047,000USD | 1,664,000USD |
| Change To Account Receivables | -5,497,000USD | -4,684,000USD |
| Change To Inventory | -23,781,000USD | -8,753,000USD |
| Change In Working Capital | -32,570,000USD | -11,989,000USD |
| Total Cash From Operating Activities | -53,608,000USD | -55,214,000USD |
| Capital Expenditures | -6,384,000USD | -3,388,000USD |
| Free Cash Flow | -59,992,000USD | -58,602,000USD |
| Investments | 52,560,000USD | -50,545,000USD |
| Total Cashflows From Investing Activities | 46,176,000USD | — |
| Net Borrowings | 10,000,000USD | -15,000,000USD |
| Total Cash From Financing Activities | 10,836,000USD | 113,417,000USD |
| Issuance Of Capital Stock | 1,493,000USD | 128,417,000USD |
| Change In Cash | 3,232,000USD | 4,269,000USD |
| Begin Period Cash Flow | 31,677,000USD | 27,408,000USD |
| End Period Cash Flow | 34,909,000USD | 31,677,000USD |
| Other Cashflows From Investing Activities | -1,011,000USD | — |
| Other Cashflows From Financing Activities | -657,000USD | — |
| Unclassified Investing Cash Flow | 1,011,000USD | — |
| Unclassified Operating Cash Flow | — | -1,883,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | Americas | 1,287,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 2,409,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 3,972,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United Kingdom | 3,462,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 14,905,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Product | Consumables | 13,960,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Product | Instruments | 7,381,000 | USD | 0001193125-26-213424 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 4,694,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Americas | 20,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 450,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 1,422,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United Kingdom | 1,730,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 9,469,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Product | Consumables | 5,023,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Product | Instruments | 4,146,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 250,000 | USD | 0001193125-26-213424 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 3,672,000 | USD | 0001193125-26-213424 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.